Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B levels in epithelial lining fluid under treatment with lipid-formulated amphotericin B
2005-003609-96Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amphotericin b in fungal pneumonia (3 arms), sponsored by Medical University of South Carolina. Primary endpoint: Concentration of lipid-formulated amphotericin B in epithelial lining fluid. Started Sep 2005; status: completed.
02
Drugs
amphotericin b
03
Conditions
fungal pneumonia
Beyond the preview
Go deeper on 2005-003609-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003609-96.